GenScript Forum Debuts in Europe, Gene Therapy Breakthroughs
21 Nov 2024 //
PR NEWSWIRE
GenScript Subsidiary ProBio Aids Latest Cancer Fight
15 Nov 2024 //
PR NEWSWIRE
GenScript Biotech Forum in London to Discuss Cell & Gene Therapies
13 Nov 2024 //
PR NEWSWIRE
GenScript sets up operations and logistics center in Australia
11 Nov 2024 //
FIERCE PHARMA
Global Bio Leaders Gather For 2024 GenScript Forum In London
24 Oct 2024 //
PR NEWSWIRE
Legend sheds Genscript as its majority shareholder
23 Oct 2024 //
FIERCE PHARMA
GenScript`s Legend Biotech Gets Cilta-cel Approval In China For Multiple Myeloma
27 Aug 2024 //
PR NEWSWIRE
Multiply Labs, GenScript Collab on Cell Therapy Manufacturing Automation
25 Apr 2024 //
BUSINESSWIRE
GenScript Bio Global Forum 2024 to Commence Vitality into GCT Industry
04 Jan 2024 //
PR NEWSWIRE
GenScript Named a BioSpace 2024 Best Place to Work
01 Dec 2023 //
PR NEWSWIRE
GenScript Expands Range of Reagent Services
18 Sep 2023 //
PR NEWSWIRE
GenScript Expands Peptide Production Capabilities to Include Neoantigen Peptides
08 Aug 2023 //
PR NEWSWIRE
GenScript to Host Third Annual Gene & Cell Engineering Virtual Summit
20 Jul 2023 //
PR NEWSWIRE
GenScript Doubles cGMP sgRNA Manufacturing Capacity
06 Jul 2023 //
CONTRACT PHARMA
GenScript Unveils GenTitan Gene Fragments Service
23 May 2023 //
CONTRACT PHARMA
GenScript Expands Production Facility in China
18 May 2023 //
CONTRACT PHARMA
GenScript, Allozymes Partner to Advance Enzyme Discovery and Development
07 Dec 2022 //
CONTRACTPHARMA
GenScript & Avectas Partner to Develop Cell Therapy Manufacturing Process
21 Sep 2022 //
CONTRACTPHARMA
Genscript Biotech Reports 2022 Interim Results*
31 Aug 2022 //
PRNEWSWIRE
GenScript Launches Expedited mRNA Service for Pre-Clinical Applications
17 Aug 2022 //
PRNEWSWIRE
GenScript Biotech collaborates with Singapore Institute of Technology
27 May 2022 //
BIOSPECTRUMASIA
GenScript ProBio builds up presence in APAC
13 May 2022 //
BIOSPECTRUMASIA
GenScript drops a modest investment into its supply capacity as business booms
04 Nov 2021 //
ENDPTS
GenScript establishes Korean legal entity to accelerate commercialization
05 Oct 2021 //
BIOSPECTRUMASIA
GenScript establishes Korean legal entity and accelerates sales activities
04 Oct 2021 //
ASIAONE
GenScript establishes Korean legal entity and accelerates sales activities
04 Oct 2021 //
ASIAONE
GenScript Biotech reports results for the first half of 2021
25 Aug 2021 //
PRNEWSWIRE
Genscript Biotech Reports 2021 Interim Financial Results
23 Aug 2021 //
PRNEWSWIRE
GenScript partners Allozymes provide smart libraries for precision engineering
03 Aug 2021 //
BIOSPECTRUM ASIA
GenScript Launches Research Lentiviral Vector Packaging Service
29 Apr 2021 //
CONTRACTPHARMA
GenScript, G42 Healthcare provide innovative solutions to fight COVID-19
17 Mar 2021 //
BIOSPECTRUMASIA
GenScript and InnoBation enter into agreement for CAR-T therapy
18 Dec 2020 //
BIOSPECTRUMASIA
Through Strategic Collaboration with GenScript ProBio, Initium Therapeutics
07 Dec 2020 //
PRNEWSWIRE
Genscript, Legend Biotech founder arrested in China for suspected smuggling
24 Nov 2020 //
ENDPTS
Genscript, Legend Biotech founder arrested in China for suspected smuggling
23 Nov 2020 //
FIERCE PHARMA
GenScript Receives FDA Emergency Use Authorization for World`s First SARS-CoV-2
09 Nov 2020 //
PRNEWSWIRE
US FDA grants EUA to GenScript’s cPass SARS-CoV-2 neutralization antibody
09 Nov 2020 //
PHARMABIZ
GenScript Receives FDA Emergency Use Authorization for World`s First SARS-CoV-2
09 Nov 2020 //
PRNASIA
Premas to distribute Genscript`s cPassTM SARS CoV-2 Detection Kit in India
06 Oct 2020 //
BIOSPECTRUMASIA
GenScript Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T
24 Sep 2020 //
PRNEWSWIRE
J&J CAR-T partner Legend`s new CEO under `residential surveillance` Chinese
21 Sep 2020 //
FIERCE PHARMA
Rocked by customs investigation, Legend`s CFO takes over as CEO Frank Zhang
21 Sep 2020 //
ENDPTS
GenScript ProBio Licenses Global Rights for SMAB Bispecific to REMD
17 Sep 2020 //
PRNASIA
GenScript Reports 2020 Interim Results and Provides Business Update
31 Aug 2020 //
PRNEWS WIRE
GenScript Reports 2020 Interim Results and Provides Business Update
30 Aug 2020 //
PRNEWSWIRE
GenScript Biotech Corporation enters strategic distributor partnership Premas
27 Aug 2020 //
BIOSPECTRUMASIA
GenScript Biotech Corporation enters strategic partnership with Premas
07 Aug 2020 //
BIOSPECTRUMASIA
Genscript chief, the majority shareholder of Legend, China biotech’s new CEO
04 Aug 2020 //
FIERCE BIOTECH
GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript CelL
21 Jul 2020 //
PRNASIA
GenScript and Genopis Enter Partnership
20 Jan 2020 //
CONTRACT PHARMA
GenScript and Selecxine Enter Into Strategic Cooperation Agreement
27 Dec 2019 //
PR NEWSWIRE